source
- WHO advises against GLP-1 obesity drugs for children under 10, limits use in teensThe World Health Organization issued guidance recommending that GLP-1 drugs not be used to treat obesity in children younger than ten years old. For adolescents aged 10 to 19, the WHO says these m…
- PhRMA sues Trump administration over Medicare GLOBE price pilotPhRMA filed a lawsuit in the U.S. District Court for the District of Columbia challenging the Trump administration's GLOBE pilot that would tie Medicare Part B drug prices to those in peer nations.…